UPDATE: Jefferies Reiterates Hold Rating, Raises PT on ResMed
Posted on January 25, 2013 at 10:27 AM EST
In a report published Friday, Jefferies reiterated its Hold rating on ResMed (NYSE: RMD ), and raised its price target from $35.00 to $42.00. Jefferies noted, “RMD reported strong FQ2 results with revs and EPS beating by $13mm and $0.02. The upside was across the board, albeit off favorable year